Risk for Intracranial Hemorrhage after Tissue Plasminogen Activator Treatment for Acute Myocardial Infarction
作者： Jerry H Gurwitz , Joel M Gore , Robert J Goldberg , Hal V Barron , Timothy Breen
DOI: 10.7326/0003-4819-129-8-199810150-00002
关键词: Surgery 、 Heparin 、 Vascular disease 、 Medicine 、 Anticoagulant 、 Thrombolysis 、 Cardiology 、 Tissue plasminogen activator 、 Electrocardiography in myocardial infarction 、 Internal medicine 、 Myocardial infarction 、 Stroke 、 General Medicine
摘要: Background: The efficacy of thrombolytic therapy in reducing mortality from acute myocardial infarction has been unequivocally shown. However, thrombolysis is related to bleeding complications, inc...
sci-hub.se 参考文章(13)
Alan Tiefenbrunn, Michael Rubison, Joel M. Gore, William J. French, Costas Lambrew, Richard C. Becker, William Rogers, Association Between Body Weight and In-Hospital Clinical Outcome Following Thrombolytic Therapy: A Report from the National Registry of Myocardial Infarction. Journal of Thrombosis and Thrombolysis. ,vol. 2, pp. 231- 237 ,(1995) , 10.1007/BF01062715
Johan Herlitz, Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients The Lancet. ,vol. 343, pp. 311- 322 ,(1994)
Stanley Lemeshow, David W. Hosmer, Applied Logistic Regression ,(1989)
HD White, GI Barbash, M Modan, J Simes, R Diaz, JR Hampton, J Heikkilä, A Kristinsson, S Moulopoulos, EA Paolasso, None, After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study. Circulation. ,vol. 88, pp. 2097- 2103 ,(1993) , 10.1161/01.CIR.88.5.2097
Thomas Killip, John T. Kimball, Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients American Journal of Cardiology. ,vol. 20, pp. 457- 464 ,(1967) , 10.1016/0002-9149(67)90023-9
Harlan M Krumholz, Jaime E Murillo, Jersey Chen, Viola Vaccarino, Martha J Radford, Edward F Ellerbeck, Yun Wang, Thrombolytic Therapy for Eligible Elderly Patients With Acute Myocardial Infarction JAMA: The Journal of the American Medical Association. ,vol. 277, pp. 1683- 1688 ,(1997) , 10.1001/JAMA.1997.03540450039032
Jerry H Gurwitz, Nananda F Col, Jerry Avorn, The Exclusion of the Elderly and Women From Clinical Trials in Acute Myocardial Infarction JAMA: The Journal of the American Medical Association. ,vol. 268, pp. 1417- 1422 ,(1992) , 10.1001/JAMA.1992.03490110055029
Jerry H. Gurwitz, Coronary Thrombolysis for the Elderly JAMA. ,vol. 277, pp. 1723- 1724 ,(1997) , 10.1001/JAMA.1997.03540450079040
J M Gore, M Sloan, T R Price, A M Randall, E Bovill, D Collen, S Forman, G L Knatterud, G Sopko, M L Terrin, Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial. Circulation. ,vol. 83, pp. 448- 459 ,(1991) , 10.1161/01.CIR.83.2.448
Scott D. Berkowitz, Christopher B. Granger, Karen S. Pieper, Kerry L. Lee, Joel M. Gore, Maarten Simoons, Paul W. Armstrong, Eric J. Topol, Robert M. Califf, Incidence and Predictors of Bleeding After Contemporary Thrombolytic Therapy for Myocardial Infarction Circulation. ,vol. 95, pp. 2508- 2516 ,(1997) , 10.1161/01.CIR.95.11.2508